LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,149
تعداد مقالات10,518
تعداد مشاهده مقاله45,415,485
تعداد دریافت فایل اصل مقاله11,291,272
Mehdizadeh, A R, Bevelacqua, J J, Mortazavi, S A R, Mortazavi, S M J. (1399). COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn’t Induce Selective Pressure and New Mutations. سامانه مدیریت نشریات علمی, 10(3), 247-250. doi: 10.31661/jbpe.v0i0.2005-1114
A R Mehdizadeh; J J Bevelacqua; S A R Mortazavi; S M J Mortazavi. "COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn’t Induce Selective Pressure and New Mutations". سامانه مدیریت نشریات علمی, 10, 3, 1399, 247-250. doi: 10.31661/jbpe.v0i0.2005-1114
Mehdizadeh, A R, Bevelacqua, J J, Mortazavi, S A R, Mortazavi, S M J. (1399). 'COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn’t Induce Selective Pressure and New Mutations', سامانه مدیریت نشریات علمی, 10(3), pp. 247-250. doi: 10.31661/jbpe.v0i0.2005-1114
Mehdizadeh, A R, Bevelacqua, J J, Mortazavi, S A R, Mortazavi, S M J. COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn’t Induce Selective Pressure and New Mutations. سامانه مدیریت نشریات علمی, 1399; 10(3): 247-250. doi: 10.31661/jbpe.v0i0.2005-1114

COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn’t Induce Selective Pressure and New Mutations

Journal of Biomedical Physics and Engineering
مقاله 1، دوره 10، شماره 3، شهریور 2020، صفحه 247-250    اصل مقاله (310.41 K)
نوع مقاله: Editorial
شناسه دیجیتال (DOI): 10.31661/jbpe.v0i0.2005-1114
نویسندگان
A R Mehdizadeh1؛ J J Bevelacqua2؛ S A R Mortazavi3؛ S M J Mortazavi* 1
1PhD, Department of Medical Physics, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
2PhD, Bevelacqua Resources, Richland, Washington 99352, United States.
3MD, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn’t Induce Selective Pressure and New Mutations COVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn’t Induce Selective Pressure and New MutationsCOVID-19: Introducing Low Dose Radiation as an Effective Treatment for Pneumonia that Shouldn’t Induce Selective Pressure and New Mutations
کلیدواژه‌ها
COVID-19؛ Introducing؛ Low Dose Radiation
سایر فایل های مرتبط با مقاله
مراجع
  1. Yao HP, Lu X, Chen Q, Xu K, Chen Y, Cheng L, Liu F, Wu Z, Wu H, Jin C, Zheng M. Patient-derived mutations impact pathogenicity of SARS-CoV-2. medRxiv. 2020. doi: 10.1101/2020.04.14.20060160.
  2. Young K. NIH Publishes COVID-19 Treatment Guidelines. Medical News | PHYSICIAN’S FIRST WATCH; David G. Fairchild, and Lorenzo Di Francesco, editors. NIH; 2020.
  3. Desai AN, Patel P. Stopping the spread of COVID-19. Jama. 2020;323(15):1516. doi: 10.1001/jama.2020.4269.
  4. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. Jama. 2020.
  5. Calabrese EJ, Dhawan G. How radiotherapy was historically used to treat pneumonia: could it be useful today? Yale J Biol Med. 2013;86(4):555-70. PubMed PMID: 24348219. PubMed PMCID: PMC3848110
  6. Ghadimi-Moghadam A, Haghani M, Bevelacqua JJ, Jafarzadeh A, et al. COVID-19 tragic pandemic: concerns over unintentional “directed accelerated evolution” of novel Coronavirus (SARS-CoV-2) and introducing a modified treatment method for ARDS. J Biomed Phys Eng. 2020;10(2):241-6. doi: 10.31661/jbpe.v0i0.2003-1085. PubMed PMID: 32337192. PubMed PMCID: PMC7166223.
  7. Irwin KK, Renzette N, Kowalik TF, Jensen JD. Antiviral drug resistance as an adaptive process. Virus Evol. 2016;2(1):vew014. doi: 10.1093/ve/vew014. PMID: 28694997. PMCID: PMC5499642.
  8. Porta C, Riboldi E, Ippolito A, Sica A. Molecular and epigenetic basis of macrophage polarized activation. Seminars in immunology. 2015;27(4):237-48. doi: 10.1016/j.smim.2015.10.003.
  9. Kirkby C, Mackenzie M. Is low dose radiation therapy a potential treatment for COVID-19 pneumonia? Radiotherapy and Oncology. 2020. doi: 10.1016/j.radonc.2020.04.004. PubMed PMID:32342871. PubMed PMCID: PMC7194710.
  10. Lara PC, Burgos J, Macias D. Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment. Clinical and Translational Radiation Oncology. 2020;23:27-9. doi: 10.1016/j.ctro.2020.04.006.
  11. Montero A, Arenas M, Algara M. Low-dose radiation therapy: could it be a game-changer for COVID-19? Clinical & Translational Oncology. 2020:1. doi: 10.1007/s12094-020-02401-y.
  12. Cosset JM, Deutsch É, Bazire L, Mazeron JJ, Chargari C. Irradiation pulmonaire ā faible dose pour l’orage de cytokines du covid-19: pourquoi pas? Cancer Radiother. 2020. doi: 10.1016/j.canrad.2020.04.003. PubMed PMID: 32389579. PubMed PMCID: PMC7252150.
  13. Meziani L, Robert C, Mordant P, Deutsch E. Low doses of radiation therapy increase the immunosuppressive profile of lung macrophages via IL-10 production and IFNγ/IL-6 suppression: a therapeutic strategy to counteract lung inflammation? bioRxiv. 2020. doi: 10.1101/2020.05.11.0776511.
  14. Dhawan G, Kapoor R, Dhawan R, Singh R, Monga B, Giordano J, Calabrese EJ. Low dose radiation therapy as a potential life saving treatment for COVID-19-induced acute respiratory distress syndrome (ARDS). Radiotherapy and Oncology. 2020. doi: 10.1016/j.radonc.2020.05.002.
  15. Rödel F, Arenas M, Ott OJ, Fournier C, Georgakilas AG, Tapio S, Trott KR, Gaipl US. Low-dose radiation therapy for COVID-19 pneumopathy: what is the evidence?. Strahlentherapie und Onkologie. 2020:1-4. doi: 10.1007/s00066-020-01635-7.
  16. Venkatraman P, Sahay JJ, Maidili T, Rajan R, Pooja S. Breakthrough of COVID-19 using radiotherapy treatment modalities. Radiotherapy and Oncology. 2020;148:225-6. doi: 10.1016/j.radonc.2020.04.024.
  17. Poortmans PM, Guarneri V, Cardoso M-J. Cancer and COVID-19: what do we really know? The Lancet. 2020. doi.org/10.1016/S0140-6736(20)31240-X.
  18. Willyard C. Coronavirus blood-clot mystery intensifies. Nature. 2020.
  19. Klok FA, Kruip MJH, Van Der Meer NJM, Arbous MS, Gommers D, Kant KM, Kaptein FHJ, Van Paassen J, Stals MAM, Huisman MV, Endeman H. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. 2020. doi: 10.1016/j.thromres.2020.04.041.
  20. Poissy J, Goutay J, Caplan M, Parmentier E, Duburcq T, Lassalle F, Jeanpierre E, Rauch A, Labreuche J, Susen S. Pulmonary embolism in COVID-19 patients: awareness of an increased prevalence. Circulation. 2020. doi: 10.1161/CIRCULATIONAHA.120.047430.
  21. Violi F, Pignatelli P. Platelet oxidative stress and thrombosis. Thrombosis research. 2012;129(3):378-81. doi: 10.1016/j.thromres.2011.12.002.
آمار
تعداد مشاهده مقاله: 2,565
تعداد دریافت فایل اصل مقاله: 878


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب